Page last updated: 2024-11-03

proglumide and Biliary Tract Cancer

proglumide has been researched along with Biliary Tract Cancer in 1 studies

Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogura, Y1
Matsuda, S1
Itho, M1
Sasaki, H1
Tanigawa, K1
Shimomura, M1

Other Studies

1 other study available for proglumide and Biliary Tract Cancer

ArticleYear
Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
    World journal of surgery, 2002, Volume: 26, Issue:3

    Topics: Adenocarcinoma, Papillary; Animals; Autoradiography; Biliary Tract Neoplasms; Carcinogens; Cholecyst

2002